Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Altieri

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 28, 2024
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation studyGianpaolo Maggi, Manuela Altieri, Mario Risi, et al.
AIMS Neuroscience|July 28, 2025
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary studyRosa Giacca, Miriana Conte, Alessandro d'Ambrosio, et al.
Journal of Neurology|July 25, 2022
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimodRocco Capuano, Manuela Altieri, Miriana Conte, et al.
Multiple Sclerosis and Related Disorders|March 10, 2022
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimodRocco Capuano, Alvino Bisecco, Miriana Conte, et al.
AJNR. American Journal of Neuroradiology|June 23, 2026
T1W/T2W Ratio to Assess Brain Microstructural Damage in Multiple Sclerosis: A Multicenter StudyLoredana Storelli, Paolo Preziosa, Nicolò Tedone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 27, 2023
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidenceManuela Altieri, Rosario Domenico Melisi, Miriana Conte, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 4, 2019
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosisAlvino Bisecco, Rocco Capuano, Giuseppina Caiazzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2024
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosisGianpaolo Maggi, Manuela Altieri, Mario Risi, et al.
Journal of Neurology|May 6, 2026
Refining neuropsychological assessment strategies in multiple sclerosis: insights from long-term cognitive trajectoriesGianpaolo Maggi, Manuela Altieri, Alessandro d'Ambrosio, et al.
Human Brain Mapping|October 18, 2022
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data setChiara Marzi, Alessandro d'Ambrosio, Stefano Diciotti, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 28, 2024
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation studyGianpaolo Maggi, Manuela Altieri, Mario Risi, et al.
AIMS Neuroscience|July 28, 2025
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary studyRosa Giacca, Miriana Conte, Alessandro d'Ambrosio, et al.
Journal of Neurology|July 25, 2022
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimodRocco Capuano, Manuela Altieri, Miriana Conte, et al.
Multiple Sclerosis and Related Disorders|March 10, 2022
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimodRocco Capuano, Alvino Bisecco, Miriana Conte, et al.
AJNR. American Journal of Neuroradiology|June 23, 2026
T1W/T2W Ratio to Assess Brain Microstructural Damage in Multiple Sclerosis: A Multicenter StudyLoredana Storelli, Paolo Preziosa, Nicolò Tedone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 27, 2023
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidenceManuela Altieri, Rosario Domenico Melisi, Miriana Conte, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 4, 2019
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosisAlvino Bisecco, Rocco Capuano, Giuseppina Caiazzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 27, 2024
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosisGianpaolo Maggi, Manuela Altieri, Mario Risi, et al.
Journal of Neurology|May 6, 2026
Refining neuropsychological assessment strategies in multiple sclerosis: insights from long-term cognitive trajectoriesGianpaolo Maggi, Manuela Altieri, Alessandro d'Ambrosio, et al.
Human Brain Mapping|October 18, 2022
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data setChiara Marzi, Alessandro d'Ambrosio, Stefano Diciotti, et al.
Pageof 4